Management of Symptomatic Bradycardia in Inferior MI

Pathophysiology and Clinical Presentation

• Sinus bradycardia is common in the first hours of STEMI, especially in inferior MI, often due to increased vagal tone (Bezold-Jarish reflex) 1, 2
• Bradycardia in inferior MI is usually associated with AV block at the supra-Hisian level and often resolves spontaneously or after reperfusion 1, 3

Initial Management Algorithm

• For symptomatic bradycardia in inferior myocardial infarction with suspected vagal tone dysfunction, intravenous atropine is the first-line treatment, followed by temporary pacing if atropine fails to improve heart rate and hemodynamics, as recommended by the European Heart Journal 1, 2
• Heart rate typically less than 50 bpm with systolic BP less than 80-90 mmHg is an indication for intervention 4, 5
• The American College of Cardiology recommends atropine as the first-line treatment for symptomatic sinus bradycardia or symptomatic AV block occurring at the AV nodal level (second-degree type I or third-degree with narrow-complex escape rhythm) 4, 5, 6
• Atropine dosing is 0.5-1 mg IV, may be repeated every 3-5 minutes to a maximum total dose of 3 mg, with a target to achieve minimally effective heart rate (approximately 60 bpm) 4, 5, 6, 7

Temporary Pacing

• Temporary pacing is indicated when there is failure to respond to positive chronotropic medication, as recommended by the European Heart Journal 1, 2
• Transcutaneous pacing is the first choice for immediate intervention, while transvenous pacing is considered if prolonged pacing support is anticipated 4, 5

Alternative Pharmacologic Agents

• Epinephrine may be used as an alternative pharmacologic agent at a dose of 2-10 mcg/min IV or 0.1-0.5 mcg/kg/min IV titrated to desired effect 6, 7
• Dopamine may be used as an alternative pharmacologic agent at a dose of 5-20 mcg/kg/min IV, starting at 5 mcg/kg/min and increasing by 5 mcg/kg/min every 2 minutes 6, 7
• Isoproterenol may be used as an alternative pharmacologic agent at a dose of 1-20 mcg/min based on heart rate response, but with caution due to risk of increasing myocardial oxygen demand 6, 7

Special Considerations

• Atropine should be used with caution in MI due to potential loss of protective parasympathetic tone against VF and myocardial infarct extension, as recommended by the American College of Cardiology 4, 5
• Revascularization should be considered urgent angiography with a view to revascularization if the patient has not received previous reperfusion therapy, as recommended by the European Heart Journal 1, 2
• Continuous ECG monitoring for progression of conduction abnormalities is recommended by the American College of Cardiology 4, 5, 6

Expected Outcomes

• AV block in inferior MI usually resolves within 72 hours as the acute ischemia improves, as reported by the European Heart Journal 1, 3

Potential Complications

• Temporary pacing complications include vascular injury, pneumothorax (with transvenous approach), pain (with transcutaneous approach), and infection, as reported by the American College of Cardiology 4, 5

Vasopressin in Bradyarrhythmia from Inferior STEMI

Clinical Context

• The European Society of Cardiology recommends vasopressin as a positive chronotropic medication for hemodynamically unstable bradyarrhythmia in inferior STEMI, specifically when there is hemodynamic intolerance or high-degree AV block without a stable escape rhythm 8, 9, 10
• Bradyarrhythmias are common in inferior STEMI due to increased vagal tone and typically involve supra-Hisian AV block that often resolves spontaneously or after reperfusion, according to the European Heart Journal 11, 8

Treatment Algorithm

• The American College of Cardiology recommends atropine as the initial drug of choice for symptomatic bradycardia with hemodynamic compromise, with a dosing of 0.5-1.0 mg IV bolus, repeated every 3-5 minutes to maximum 3 mg total dose 12
• The European Society of Cardiology explicitly recommends intravenous positive chronotropic medications including epinephrine, vasopressin, and/or atropine as Class I, Level C indication when atropine fails or is insufficient 8, 9, 10
• Temporary pacing is indicated when positive chronotropic medications fail, according to the European Heart Journal 8, 9, 10

Critical Considerations

• Urgent angiography with revascularization is indicated if the patient has not received previous reperfusion therapy, as this addresses the underlying cause of the bradyarrhythmia, recommended by the European Society of Cardiology 8, 9, 10
• The European Society of Cardiology recommends not to withhold vasopressin or other chronotropic agents while waiting for temporary pacing setup in hemodynamically unstable patients, placing vasopressin at the same recommendation level (Class I) as atropine for this specific indication 8, 9, 10